PMI has established a wellness investment corridor to access the growing consumer health market and address unmet consumer needs by leveraging Fertin’s innovation and manufacturing capabilities, as well as the capabilities of carefully selected external partners.

PMI aims to commercialize scientifically substantiated botanical products that help people take well-being into their own hands and is exploring opportunities to enter the cannabinoid (CBD) space for consumer health.